Hepatitis C Virus RNA Persists in Liver Explants of Most Patients Awaiting Liver Transplantation Treated With an Interferon-Free Regimen

Gastroenterology

Volumn 151, Issue 4, 2016, Pages 633-636.e3

  Gambato, Martina ^a   Pérez del Pulgar, Sofía ^a   Hedskog, Charlotte ^b   Svarovskia, Evguenia S ^b   Brainard, Diana ^b   Denning, Jill ^b   Curry, Michael P ^c   Charlton, Michael ^d   Caro Pérez, Noelia ^a   Londoño, Maria Carlota ^a   Koutsoudakis, George ^a   Forns, Xavier ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

^b GILEAD SCIENCES   (United States)

^c BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^d INTERMOUNTAIN MEDICAL CENTER   (United States)

Author keywords

DAA; IFN free; SVR; Viral Persistence

Indexed keywords

ANTIVIRUS AGENT; DACLATASVIR; LEDIPASVIR; LEDIPASVIR PLUS SOFOSBUVIR; RIBAVIRIN; SIMEPREVIR; SOFOSBUVIR; VIRUS RNA;

ADULT; ANTIVIRAL THERAPY; ARTICLE; BLOOD LEVEL; CHILD PUGH SCORE; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG RESPONSE; EXPLANT; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HOSPITAL ADMISSION; HUMAN; LIVER; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; MALE; MODEL FOR END STAGE LIVER DISEASE SCORE; OPEN STUDY; PHASE 2 CLINICAL TRIAL (TOPIC); PHASE 3 CLINICAL TRIAL (TOPIC); PILOT STUDY; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PREVALENCE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RECURRENT INFECTION; RELAPSE; RNA ANALYSIS; RNA EXTRACTION; SHORT COURSE THERAPY; TREATMENT DURATION; BLOOD; DRUG EFFECTS; GENETICS; HEPACIVIRUS; MIDDLE AGED; RECURRENT DISEASE; SUSTAINED VIROLOGIC RESPONSE; TRANSPLANTATION; VIROLOGY;

ANTIVIRAL AGENTS; FEMALE; HEPACIVIRUS; HEPATITIS C; HUMANS; LIVER; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; RECURRENCE; RNA, VIRAL; SUSTAINED VIROLOGIC RESPONSE; TRANSPLANTS; WAITING LISTS;

EID: 84989835812     PISSN: 00165085     EISSN: 15280012     Source Type: Journal    
DOI: 10.1053/j.gastro.2016.06.025     Document Type: Article

References (11)

1. 1 Forns, X., et al. J Hepatol 39 (2003), 389–396.
2. 2 Gambato, M., et al. J Hepatol 61 (2014), 120–131.
3. 3 Curry, M.P., et al. Gastroenterology 148 (2015), 100–107.
4. 4 Charlton, M., et al. Gastroenterology 149 (2015), 649–659.
5. 5 Manns, M., et al. Lancet Infect Dis 16 (2016), 685–697.
6. 6 Pawlotsky, J.M., Gastroenterology 151 (2016), 70–86.
7. 7 Veerapu, N.S., et al. J Clin Invest 124 (2014), 3469–3478.
8. 8 Ralston, R., et al. Semin Liver Dis 31 (2011), 410–419.
9. 9 Ramirez, S., et al. Am J Transplant 9 (2009), 1591–1601.
10. 10 Meissner, E.G., et al. J Clin Invest 124 (2014), 3352–3363.
11. 11 Liang, Y., et al. Gastroenterology 137 (2009), 1448–1458.